Product Information
DOXAZOSIN MESYLATE 1 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0772 per EA under NDC 59762138807. Its NADAC has been published 56 times since Jul 30, 2025.
FDA first approved this application on Nov 2, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the doxazosin mesylate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762138807
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DOXAZOSIN MESYLATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019668FDA Approved
11/2/1990
TE Code
AB
On Market Since
5/9/2025
Pharmacological Classes
Price Statistics
The NADAC for DOXAZOSIN MESYLATE 1 MG TAB has been published 56 times since Jul 30, 2025, and over the history we have for it it has declined 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0772 per EA |
|---|---|
| All-time high | $0.0856 (Feb 11, 2026) |
| All-time low | $0.0763 (Jun 17, 2026) |
| 52-week high | $0.0856 |
| 52-week low | $0.0763 |
| Median price | $0.0810 |
| Average price | $0.0808 |
| Largest weekly change | +8.3% (Jul 22, 2026) |
| Weeks tracked | 56 |
| Tracking since | Jul 30, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DOXAZOSIN MESYLATE 1 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DOXAZOSIN MESYLATE 1 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.0772 per EA (NDC 59762138807), effective Aug 19, 2026.
How has the price of DOXAZOSIN MESYLATE 1 MG TAB changed over time?
Over the history we have for it, the NADAC for DOXAZOSIN MESYLATE 1 MG TAB has declined 6.6%. It has been tracked across 56 weekly CMS publications since Jul 30, 2025.
What are the highest and lowest recorded NADAC prices for DOXAZOSIN MESYLATE 1 MG TAB?
Since Jul 30, 2025, the NADAC for DOXAZOSIN MESYLATE 1 MG TAB has ranged from a low of $0.0763 (Jun 17, 2026) to a high of $0.0856 (Feb 11, 2026), with a median of $0.0810 per EA.
Are there cheaper alternatives to DOXAZOSIN MESYLATE 1 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOXAZOSIN MESYLATE 1 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DOXAZOSIN MESYLATE 1 MG TAB?
DOXAZOSIN MESYLATE 1 MG TAB (NDC 59762138807) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.